For the quarter ending 2025-09-30, LCTC had -$310,653 decrease in cash & cash equivalents over the period. -$205,561 in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net (loss) | -263,439 | -686,325 |
| Depreciation and amortization | 108,676 | 216,419 |
| Provision for doubtful accounts, net change | -1,500 | 0 |
| Provision for inventory obsolescence, net change | 0 | 0 |
| Deferred taxes, net change | 0 | 0 |
| Amortization of debt issuance costs | 6,051 | 5,886 |
| Accounts receivable | 100,226 | 33,189 |
| Inventories | -126,594 | -7,645 |
| Federal and state income taxes receivable | -49,758 | 25,029 |
| Prepaid expenses and other | -17,451 | 120,034 |
| Deposits and other | -34,559 | 0 |
| Accounts payable | -8,077 | 141,419 |
| Income taxes payable | 0 | 0 |
| Customer and tenant deposits | -19,699 | -6,186 |
| Accrued expenses | -20,663 | 55,416 |
| Deferred revenue | -2,170 | 4,344 |
| Net cash (used in) operating activities | -188,861 | -389,576 |
| Purchases of property and equipment | 16,700 | 22,810 |
| Purchases of research and development equipment, software and space modifications not in service | 91,205 | 219,441 |
| Patent filing cost | 0 | 0 |
| Net cash (used in) investing activities | -107,905 | -242,251 |
| Principal payments made on term loan | 13,887 | 27,469 |
| Proceeds from issuance of 210,000 shares of common stock at 3.80 per share | 0 | - |
| Proceeds from issuance of subordinated debenture | 0 | 75,000 |
| Issuance of shares from option exercise | - | 336,300 |
| Proceeds from issuance of shares from option exercise | 336,300 | - |
| Net cash provided from financing activities | -13,887 | 383,831 |
| Net (decrease) in cash | -310,653 | -247,996 |
| Cash and cash equivalents at beginning of period | 1,243,746 | - |
| Cash and cash equivalents at end of period | 685,097 | - |
Lifeloc Technologies, Inc (LCTC)
Lifeloc Technologies, Inc (LCTC)